Dmxl1 was knocked down in WT iBMDMs or
Tpl2[D270A] iBMDMs by RNA interference using a SMARTpool ON‐TARGETplus siRNA for 48 h. ON‐TARGETplus non‐targeting pool functioned as siRNA control. (C) qRT–PCR analysis of RNA extracted from iBMDMs was used to check the efficiency of
Dmxl1 knockdown (D, E).
Dmxl1 mRNA levels were normalised to
Hprt mRNA levels and fold changes calculated (ΔC
t values) (
n = 4). (D) Intra‐phagosomal acidification was assayed following uptake of BCECF‐coupled latex beads by WT iBMDMs. As a control, BMDMs were pre‐treated with 1 μM bafilomycin A1 for 15 min to directly block V‐ATPase function (
n = 4 wells). (E) Intra‐phagosomal acidification was assayed following uptake of BCECF‐coupled latex beads by
Tpl2[D270A] iBMDMs (
n = 4 wells). (F) Simultaneous with
Dmxl1 siRNA knockdown, WT iBMDMs were co‐transfected with plasmids expressing either 3xFLAG‐DMXL1 (1,773–2,047) or 3xFLAG‐DMXL1 S1903A/S1904A (1,773–2,047). Intra‐phagosomal acidification was monitored as in Fig
4E (
n = 4 wells). Immunoblot analysis of total cell lysates for FLAG demonstrated similar expression levels of the two DMXL1 polypeptides in iBMDMs. qRT–PCR analysis of RNA extracted from iBMDMs confirmed that
Dmxl1 mRNA was efficiently knocked down (
n = 4) (right) in cells expressing either 3xFLAG‐DMXL1 (1,773–2,047) or 3xFLAG‐DMXL1 S1903A/S1904A (1,773–2,047).